Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Clinical Trials01:16

Clinical Trials

6.8K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
6.8K
Sample Size Calculation01:19

Sample Size Calculation

3.4K
Knowledge of the sample size is the first requirement to conduct random sampling or an experiment. The sample size is the total number of units, observations, or groups (in some cases) used to get the data to estimate a population parameter. As the name suggests, the sample size is that of the sample drawn from the population and differs from the population size.
The sample size for the given experiment or sampling effort is fundamental to any study design. Sample size decides the number of...
3.4K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

147
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
147
Study Design in Statistics01:15

Study Design in Statistics

8.2K
A study design is a set of techniques that allow a researcher to collect and analyze data from different variables defined for a specific research problem. Statistics is commonly for effective study design and more robust experiments,
Does aspirin reduce the risk of heart attacks? Is one brand of fertilizer more effective at growing roses than another? Is fatigue as dangerous to a driver as the influence of alcohol? Questions like these are answered using randomized experiments with proper...
8.2K
Statistical Software for Data Analysis and Clinical Trials01:12

Statistical Software for Data Analysis and Clinical Trials

616
Statistical software is pivotal in data analysis and clinical trials by providing tools to analyze data, draw conclusions, and make predictions. These software packages range from simple data management applications to complex analytical platforms, supporting various statistical tests, models, and simulation techniques. Their significance lies in their ability to handle vast amounts of data with precision and efficiency, enabling researchers to validate hypotheses, identify trends, and make...
616
Kaplan-Meier Approach01:24

Kaplan-Meier Approach

178
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
178

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Extending Multiple Testing With Unknown Test Dependency via the CoCo Test: With Applications to Cancer Studies.

Pharmaceutical statistics·2025
Same author

Success and Futility Criteria for Accelerated Approval of Oncology Drugs.

Pharmaceutical statistics·2025
Same author

Testing One Primary and Two Secondary Endpoints in a Two-Stage Group Sequential Trial With Extensions.

Statistics in medicine·2025
Same author

A fortune cookie problem: A test for nominal data whether two samples are from the same population of equally likely elements.

Communications in statistics: theory and methods·2024
Same author

Using Wearable Passive Sensing to Predict Binge Eating in Response to Negative Affect Among Individuals With Transdiagnostic Binge Eating: Protocol for an Observational Study.

JMIR research protocols·2023
Same author

Reverse graphical approaches for multiple test procedures.

Journal of biopharmaceutical statistics·2023

Related Experiment Video

Updated: Jul 16, 2025

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment
08:36

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment

Published on: April 19, 2024

581

Sample size optimization for clinical trials using graphical approaches for multiplicity adjustment.

Fengqing Zhang1, Jiangtao Gou2

  • 1Department of Psychological and Brain Sciences, Drexel University, Philadelphia, Pennsylvania.

Statistics in Medicine
|September 20, 2023
PubMed
Summary
This summary is machine-generated.

This study introduces statistical methods to optimize sample size in clinical trials with multiple endpoints using graphical approaches. It demonstrates how to balance clinical preferences with power requirements, improving trial design efficiency.

Keywords:
clinical trialsgraphical approachesmultiple testing proceduresnonoptimalitysample size estimation

More Related Videos

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
00:04

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition

Published on: September 20, 2019

10.7K
A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
12:18

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

Published on: January 11, 2020

7.6K

Related Experiment Videos

Last Updated: Jul 16, 2025

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment
08:36

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment

Published on: April 19, 2024

581
A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
00:04

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition

Published on: September 20, 2019

10.7K
A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
12:18

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

Published on: January 11, 2020

7.6K

Area of Science:

  • Biostatistics
  • Clinical Trial Design
  • Statistical Methodology

Background:

  • Graphical approaches are used for multiplicity adjustment in clinical trials with multiple endpoints.
  • Assigning initial weights and transition probabilities is often based on clinical importance, but lacks theoretical guidance for sample size optimization.
  • Clinical preferences can be constraints in sample size optimization, but optimal specification remains a challenge.

Purpose of the Study:

  • To propose statistical methods for optimizing sample size over initial weight and transition probability in graphical approaches for clinical trials.
  • To provide theoretical guidance for specifying weights and probabilities to meet clinical preferences while minimizing sample size.
  • To address the lack of established methods for balancing clinical importance with statistical efficiency in multi-endpoint trial design.

Main Methods:

  • Developed statistical methods to optimize sample size by considering initial weight and transition probability in graphical approaches.
  • Utilized marginal power for each endpoint as a common setting for optimization.
  • Proved the existence of optimal solutions where marginal powers precisely match prespecified values under continuity assumptions.

Main Results:

  • Demonstrated that some common graphical approaches, like concentrating all initial weights on a single endpoint, are suboptimal.
  • Proposed flexible methods applicable to single-arm and randomized controlled trials with various endpoint types (continuous, binary, mixed).
  • Illustrated the application of methods with two hypothetical clinical trial designs, extending to three or more endpoints.

Conclusions:

  • The proposed methods offer guidance for designing graphical approaches and calculating sample sizes in multi-endpoint clinical trials.
  • Optimizing initial weights and transition probabilities leads to more efficient trial designs.
  • Findings support better sample size determination by balancing clinical relevance and statistical power.